Golden Green, Inc. Immunic, Inc. Transaction History

Golden Green, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$3.13 - $12.25 $102,191 - $399,950	-32,649 Closed	0 $0
Q1 2022 Apr 18, 2022	SELL	$9.54 - $14.26 $307,769 - $460,041	-32,261 Reduced 49.7%	32,649 $369,000
Q4 2021 Jan 21, 2022	SELL	$7.34 - $10.25 $162,764 - $227,293	-22,175 Reduced 25.46%	64,910 $621,000
Q3 2021 Oct 08, 2021	BUY	$8.05 - $13.29 $47,841 - $78,982	5,943 Added 7.32%	87,085 $771,000
Q2 2021 Jul 14, 2021	SELL	$11.76 - $16.85 $38,713 - $55,470	-3,292 Reduced 3.9%	81,142 $995,000
Q1 2021 Apr 13, 2021	BUY	$14.21 - $25.3 $192,318 - $342,410	13,534 Added 19.09%	84,434 $1.35 Million
Q4 2020 Jan 25, 2021	BUY	$14.8 - $20.37 $1.05 Million - $1.44 Million	70,900 New	70,900 $1.08 Million

56M

4.7K

311K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $36.1M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Golden Green, Inc., based on Form 13F filings with the SEC.

Stay updated on Golden Green, Inc. with notifications on news.